Dynavax Technologies Corporation Statistics
Share Statistics
Dynavax Technologies Corporation has 131.46M shares outstanding. The number of shares has increased by 1.38% in one year.
| Shares Outstanding | 131.46M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.12% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 130.91M |
| Failed to Deliver (FTD) Shares | 28 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 18.84M, so 14.33% of the outstanding shares have been sold short.
| Short Interest | 18.84M |
| Short % of Shares Out | 14.33% |
| Short % of Float | 14.39% |
| Short Ratio (days to cover) | 8.88 |
Valuation Ratios
The PE ratio is -281.69 and the forward PE ratio is 37.5.
| PE Ratio | -281.69 |
| Forward PE | 37.5 |
| PS Ratio | 7.75 |
| Forward PS | 5.1 |
| PB Ratio | 2.89 |
| P/FCF Ratio | 18.66 |
| PEG Ratio | n/a |
Enterprise Valuation
Dynavax Technologies Corporation has an Enterprise Value (EV) of 1.91B.
| EV / Earnings | -298.38 |
| EV / Sales | 8.21 |
| EV / EBITDA | 197.22 |
| EV / EBIT | -51.48 |
| EV / FCF | 19.76 |
Financial Position
The company has a current ratio of 13.81, with a Debt / Equity ratio of 0.36.
| Current Ratio | 13.81 |
| Quick Ratio | 12.96 |
| Debt / Equity | 0.36 |
| Total Debt / Capitalization | 26.36 |
| Cash Flow / Debt | 0.45 |
| Interest Coverage | -5.48 |
Financial Efficiency
Return on equity (ROE) is -0.01% and return on capital (ROIC) is -6.16%.
| Return on Equity (ROE) | -0.01% |
| Return on Assets (ROA) | -0.01% |
| Return on Capital (ROIC) | -6.16% |
| Revenue Per Employee | 569.32K |
| Profits Per Employee | -15.66K |
| Employee Count | 408 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 0.94 |
Taxes
| Income Tax | 2.02M |
| Effective Tax Rate | -0.46 |
Stock Price Statistics
The stock price has increased by -5.05% in the last 52 weeks. The beta is 1.34, so Dynavax Technologies Corporation's price volatility has been higher than the market average.
| Beta | 1.34 |
| 52-Week Price Change | -5.05% |
| 50-Day Moving Average | 11.94 |
| 200-Day Moving Average | 11.6 |
| Relative Strength Index (RSI) | 60.16 |
| Average Volume (20 Days) | 2.14M |
Income Statement
In the last 12 months, Dynavax Technologies Corporation had revenue of $232.28M and earned -$6.39M in profits. Earnings per share was $-0.05.
| Revenue | 232.28M |
| Gross Profit | 182.12M |
| Operating Income | -37.03M |
| Net Income | -6.39M |
| EBITDA | 9.67M |
| EBIT | -37.03M |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has $150.28M in cash and $256.91M in debt, giving a net cash position of -$106.64M.
| Cash & Cash Equivalents | 150.28M |
| Total Debt | 256.91M |
| Net Cash | -106.64M |
| Retained Earnings | -930.58M |
| Total Assets | 1.06B |
| Working Capital | 856.21M |
Cash Flow
In the last 12 months, operating cash flow was $100.56M and capital expenditures -$4.10M, giving a free cash flow of $96.46M.
| Operating Cash Flow | 100.56M |
| Capital Expenditures | -4.10M |
| Free Cash Flow | 96.46M |
| FCF Per Share | 0.75 |
Margins
Gross margin is 78.4%, with operating and profit margins of -15.94% and -2.75%.
| Gross Margin | 78.4% |
| Operating Margin | -15.94% |
| Pretax Margin | -1.88% |
| Profit Margin | -2.75% |
| EBITDA Margin | 4.16% |
| EBIT Margin | -15.94% |
| FCF Margin | 41.53% |
Dividends & Yields
DVAX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.39% |
| FCF Yield | 5.66% |
Analyst Forecast
The average price target for DVAX is $22, which is 69.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $22 |
| Price Target Difference | 69.6% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Nov 10, 2014. It was a backward split with a ratio of 1:10.
| Last Split Date | Nov 10, 2014 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 2.76 |
| Piotroski F-Score | 5 |